marijuana
Cannabis and the workplace: a Human Resources perspective
Across all sectors, senior leadership and Human Resources departments find themselves reflecting upon some challenging questions
Investors retreat after Canopy Growth Corp. reports $1.3-billion annual loss
Canopy’s financial woes haven’t helped the share prices of other Canadian licensed weed producers.
Cannabis stocks soar—and New York tabloid ties this to study on COVID-19 prevention
The market capitalizations of Aurora, Tilray, Canopy Growth, Aphria, Cronos Group, and Hexo are all sharply higher than they were seven days earlier.
Canadian retail numbers tanked in March, but cannabis sales soared
According to StatsCan, Canadians bought $181 million worth of recreational weed in March
Aurora Cannabis shares spike in early trading following Reliva CBD takeover
Earlier this month, one financial writer described the company as the poster child of the legal weed industry’s woes.
Aurora Cannabis shares shoot up on positive quarterly numbers
Our roundup of cannabis stocks shows some improvement for Canopy Growth Corporation after a shakeup in the corporate office, but it was humdrum week for Tilray, Cronos Group, and Aphria.
Cannabis industry events in 2020: what’s still happening?
Many of the cannabis world’s industry-oriented events are still planning to go ahead as scheduled
Cronos Group CEO Mike Gorenstein says company remains agile despite challenges posed by COVID-19
It was a mixed week for investors in Canadian cannabis companies
Biz buzz: Swissx seeks soccer deal, Constellation ups its Canopy stake
Alki David says he is in talks with English Premier League team Everton